Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/12/2026

Catheter Locking in Hemodialysis – Evidence‑Based Recommendations

Definition and Clinical Rationale

  • Catheter locking involves instilling an anticoagulant (e.g., heparin or citrate) into each lumen of a hemodialysis central venous catheter at the end of every dialysis session, allowing the solution to dwell until the next session to preserve catheter patency and reduce infection risk. 1
  • The primary mechanisms are (1) prevention of lumen thrombosis and catheter dysfunction by maintaining an anticoagulant‑filled lumen, and (2) reduction of catheter‑related bloodstream infections (CRBSI) when antimicrobial agents are added to the lock solution. 2 [1][3]

Standard Locking Procedure

  • Saline flush: Each lumen should be flushed with 5–10 mL of normal saline using a turbulent technique to clear residual blood before lock solution instillation. 2
  • Lock volume: The lock solution volume must match the internal catheter volume, typically 2–5 mL per lumen. [1][3]
  • Dwell time: After instillation, the catheter is clamped and the solution is left to dwell until the next dialysis session. 2
  • Frequency: The lock solution is renewed after every dialysis treatment, generally three times per week for most patients. [1][4]5

Antibiotic Lock Therapy (Therapeutic Use for Established CRBSI)

  • Combination with systemic therapy: Antibiotic lock must always be administered together with systemic antimicrobial therapy; both are given for a total of 10–14 days. [1][4]5
  • Antibiotic‑heparin mixture: The antibiotic is mixed with heparin at supratherapeutic concentrations (approximately 100–1,000 × the minimum inhibitory concentration) and instilled into each lumen at the end of each dialysis session. [1][4]3
  • Pathogen‑specific success rates: Reported cure rates with antibiotic lock range from 87–100 % for gram‑negative infections, 75–84 % for coagulase‑negative staphylococci, and only 40–55 % for Staphylococcus aureus infections. [1][4]5

Clinical Decision Points

  • Prophylactic vs. therapeutic locking: Routine prophylactic locking uses standard anticoagulant solutions to maintain patency, whereas therapeutic antibiotic lock adds high‑concentration antibiotics to treat an active CRBSI while attempting catheter salvage. [1][3]
  • Catheter removal for high‑risk pathogens: For CRBSI caused by Staphylococcus aureus or Candida species, removal of the catheter is recommended unless no alternative vascular access site is available. [1][4]5
  • Scope of antibiotic lock: Antibiotic lock therapy eradicates infection confined to the catheter lumen only; it does not treat extraluminal or tunnel infections. 3

Heparin Lock Practices for Hemodialysis Catheters – Evidence‑Based Recommendations

Dose Appropriateness

  • Excessive administration of 12,500 units per lumen is inappropriate; the error stems from confusing heparin concentration with total dose. Clinical Infectious Diseases identified this misunderstanding. 6
  • Some legacy protocols continue to use unnecessarily high heparin concentrations for catheter locking; these outdated practices were highlighted in Clinical Nutrition. 7

Procedural Steps

  • At the end of each dialysis session, the catheter should be thoroughly flushed with normal saline to clear residual blood and prevent clot formation. This recommendation is supported by two separate studies in Clinical Nutrition. [7][8]

Infection Management

  • In patients with catheter‑related bloodstream infections, antibiotic lock therapy must be combined with heparin and systemic antibiotics (heparin alone is insufficient). Evidence from Clinical Infectious Diseases supports this combined approach. [9][6]
  • Lock solutions should be renewed after every dialysis session to maintain antimicrobial efficacy and catheter patency, as demonstrated in Clinical Infectious Diseases. [9][6]

Manufacturer Guidance

  • Manufacturers of hemodialysis blood‑processing devices recommend heparin flushing at appropriate concentrations (e.g., 1,000 units/mL) for catheter maintenance; this guidance is documented in Clinical Nutrition. [7][8]

Heparin Locks in Hemodialysis Catheters

Guideline-Based Recommendations

  • The American Society of Diagnostic and Interventional Nephrology recommends heparin 1,000 IU/mL as a suitable choice for lock solution, balancing patency maintenance with lower systemic anticoagulation risk, with high strength of evidence 10, 11, 12
  • The Kidney Disease Outcomes Quality Initiative guidelines suggest using low-concentration citrate (<5%) CVC locking solution to help prevent catheter-related bloodstream infections and CVC dysfunction, with moderate strength of evidence 13

Alternative Approaches

  • Low-concentration citrate (<5%) can be used as an alternative locking solution that provides both anticoagulant and antimicrobial properties while reducing systemic effects, with low strength of evidence 13

REFERENCES

13

Citrate Lock for Central Venous Catheters [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025